Varadhan L, Humphreys T, Walker AB, Varughese GI
10.1016/j.neuroscience.2011.02.023 Neuroscience 43 LlinsR
Competing Interests Professor Melanie Davies has acted as a consultant/advisor and speaker for Eli Lilly, Novo Nordisk and Sanofi, has attended advisory boards for Abbvie, Amgen, AstraZeneca, Biomea Fusion, Carmot/Roche, Sanofi, Zealand Pharma Regeneron, GSK and EktaH and as a speaker for AstraZeneca and Boehringer Ingelheim
Other antidiabetic drugs owing to the increased risk of hypoglycaemia, the dose of concomitant sulfonylurea and/or insulin may need to be reduced
22 Of 31 patients in the clEDS literature, 5 had experienced frequent subconjunctival hemorrhages and 4/19 patients reported this in our cohort
If you are losing weight rapidly and already approaching a low body weight, adding fasting to further restrict intake is not appropriate